Barriers to enrollment in non-small cell lung cancer therapeutic clinical trials

Journal of Thoracic Oncology

Volumn 6, Issue 1, 2011, Pages 98-102

  Baggstrom, Maria Q ^a,b   Waqar, Saiama N ^a   Sezhiyan, Ananth K ^a   Gilstrap, Eve ^a   Gao, Feng ^a   Morgensztern, Daniel ^a   Govindan, Ramaswamy ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Washington University in St Louis School of Medicine   (United States)

Author keywords

Accrual; Barriers; Clinical trial; Lung cancer; Patients

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CLINICAL TRIAL (TOPIC); COMORBIDITY; CONSULTATION; FEMALE; HEALTH INSURANCE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTPATIENT; PERFORMANCE; PRIORITY JOURNAL; TERTIARY HEALTH CARE;

EID: 78651068266     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181fb50d8     Document Type: Article

References (19)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249.
2. Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006;24:4539-4544.
3. Morgensztern D, Ng SH, Gao F, et al. Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey. J Thorac Oncol 2010;5:29-33.
4. Bunn PA Jr, Kelly K. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions. Clin Cancer Res 1998;4:1087-1100.
5. Lara PN Jr, Higdon R, Lim N, et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol 2001;19:1728-1733.
6. Metz JM, Coyle C, Hudson C, et al. An Internet-based cancer clinical trials matching resource. J Med Internet Res 2005;7:e24.
7. Fenton L, Rigney M, Herbst RS. Clinical trial awareness, attitudes, and participation among patients with cancer and oncologists. Community Oncol 2009;6:207-213.
8. Comis RL, Miller JD, Aldige CR, et al. Public attitudes toward participation in cancer clinical trials. J Clin Oncol 2003;21:830-835.
9. Takigawa N, Segawa Y, Okahara M, et al. Prognostic factors for patients with advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation. Lung Cancer 1996;15:67-77.
10. Demmy TL, Yasko JM, Collyar DE, et al. Managing accrual in cooperative group clinical trials. J Clin Oncol 2004;22:2997-3002.
11. Dilts DM, Sandler AB. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials. J Clin Oncol 2006;24:4545-4552.
12. Ellis PM. Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature. Ann Oncol 2000;11:939-945.
13. Dubey S, Hammes L, Larson ML, et al. Changing patterns of patient accrual to lung cancer clinical trials in an academic center. J Clin Oncol 2005;23:7225.
14. Bolen S, Tilburt J, Baffi C, et al. Defining "success" in recruitment of underrepresented populations to cancer clinical trials: moving toward a more consistent approach. Cancer 2006;106:1197-1204.
15. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ ethnicity and socioeconomic status. CA Cancer J Clin 2004;54:78-93.
16. Lai GY, Gary TL, Tilburt J, et al. Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials. Clin Trials 2006;3:133-141.
17. Advani AS, Atkeson B, Brown CL, et al. Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study. Cancer 2003;97:1499-1506.
18. Bennett CL, Adams JR, Knox KS, et al. Clinical trials: are they a good buy? J Clin Oncol 2001;19:4330-4339.
19. Goldman DP, Berry SH, McCabe MS, et al. Incremental treatment costs in national cancer institute-sponsored clinical trials. JAMA 2003;289: 2970-2977.